Renal Ischemia- Reperfusion |
P53/sestrin-2 pathway, HIF-1α/BNIP3 pathway |
Protect against AKI |
Modulate cell apoptosis |
[107] |
DRP1-dependent pathway |
Protect against AKI |
Eliminate damaged mitochondria |
[94] |
PINK1/PARK2 pathway |
Protect against AKI |
1. Eliminate damaged mitochondria |
[45,108] |
2. Modulate the removal of ROS |
3. Relieve inflammatory response |
4. Suppress mitochondrial depolarization |
5. Improve ATP production |
BNIP3-mediated pathway |
Protect against AKI |
1. Remove damaged mitochondria |
[109] |
2. Modulate the elimination of ROS |
3. Relieve inflammatory response |
OPA1-related pathway |
Protect against AKI |
1. Degrade the damaged mitochondria |
[110] |
2. Interrupt the mitochondrial damage signalling |
Cisplatin-induced AKI |
PINK1/PARK2 pathway |
Protect against AKI |
1. Suppress apoptosis |
[111,112,113] |
2. Protect mitochondrial function |
3. Inhibit Drp1-mediated mitochondrial fission |
DRP1-dependent pathway |
Protect against AKI |
Inhibit mitochondrial dysfunction |
[93] |
HIF-1α/BNIP3/BCEN-1 pathway |
Protect against AKI |
Alleviate apoptosis |
[114] |
Spesis-induced AKI |
PINK1/PARK2 pathway |
Protect against AKI |
Prevent cell apoptosis |
[115] |
Contrast media-Induced AKI |
PINK1/PARK2 pathway |
Protect against AKI |
1. Reduce mitochondrial ROS |
[35,116] |
2. Inhibit NLRP3 inflammasome activation |